Targeted LYmphatic and MIcrovessel Treatments in metabolic-DISease in HFpEF (LYMIT-DIS)
Researcher | Principal Investigator Heart Failure Research Group
Role of microvascular alterations in the development of heart failure with preserved ejection fraction with metabolic alterations.
- Reference: LYMIT-DIS
- Start date: March 1, 2017
- End date: February 28, 2021
- Funder: Joint Transnational Call ERA-CVD 2016 H2020 e Instituto de Salud Carlos III
- Nature of project: International
Need more information?
If you are interested in learning more about our research, please contact us